oxybutynin has been researched along with Ischemia in 6 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Transdermal nitroglycerin protects against ischemia-induced microvascular dysfunction and causes marked dilation of the brachial artery %FMD." | 9.34 | Acute application of a transdermal nitroglycerin patch protects against prolonged forearm ischemia-induced microvascular dysfunction. ( Alvares, TS; de Oliveira, GV; Murias, JM; Proctor, DN; Soares, RN, 2020) |
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 5.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
| "Transdermal nitroglycerin protects against ischemia-induced microvascular dysfunction and causes marked dilation of the brachial artery %FMD." | 5.34 | Acute application of a transdermal nitroglycerin patch protects against prolonged forearm ischemia-induced microvascular dysfunction. ( Alvares, TS; de Oliveira, GV; Murias, JM; Proctor, DN; Soares, RN, 2020) |
| "Twenty patients with ESRD were treated with Qutenza® for neuropathic pain from critical limb ischemia." | 1.46 | The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study. ( Aitken, E; Kingsmore, D; McColl, G, 2017) |
| "The treatment of chronic wounds poses a significant challenge for clinicians and patients alike." | 1.38 | Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds. ( Ganopolsky, JG; Gilardino, M; Jones, M; Labbé, A; Martoni, C; Prakash, S; Wahl, C, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kapoor, H | 1 |
| Gupta, E | 1 |
| Sood, A | 1 |
| Soares, RN | 1 |
| Proctor, DN | 1 |
| de Oliveira, GV | 1 |
| Alvares, TS | 1 |
| Murias, JM | 1 |
| Jadhav, DV | 1 |
| Mendonca, D | 1 |
| Kotinatot, S | 1 |
| Shankar, S | 1 |
| Mazmi, MA | 1 |
| Blanco-Antona, F | 1 |
| González-Sarmiento, R | 1 |
| García-Cenador, B | 1 |
| Lozano, FS | 1 |
| Aitken, E | 1 |
| McColl, G | 1 |
| Kingsmore, D | 1 |
| Jones, M | 1 |
| Ganopolsky, JG | 1 |
| Labbé, A | 1 |
| Gilardino, M | 1 |
| Wahl, C | 1 |
| Martoni, C | 1 |
| Prakash, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randonimised Trial Comparing Interrupted to Continuous Suturing Techniques in Radiocephalic Fistulae[NCT01704313] | 70 participants (Anticipated) | Interventional | 2012-05-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxybutynin and Ischemia
| Article | Year |
|---|---|
Chronic pelvic ischemia: etiology, pathogenesis, clinical presentation and management.
Topics: Aged; Animals; Atherosclerosis; Calcium; Cell Hypoxia; Chronic Pain; Disease Models, Animal; Estroge | 2014 |
1 trial available for oxybutynin and Ischemia
| Article | Year |
|---|---|
Acute application of a transdermal nitroglycerin patch protects against prolonged forearm ischemia-induced microvascular dysfunction.
Topics: Adult; Forearm; Humans; Ischemia; Male; Microcirculation; Nitroglycerin; Transdermal Patch; Vascular | 2020 |
4 other studies available for oxybutynin and Ischemia
| Article | Year |
|---|---|
Nitroglycerin patch use in digital ischemia secondary to sepsis: a case report.
Topics: Administration, Cutaneous; Fingers; Gangrene; Humans; Infant, Newborn; Ischemia; Male; Neonatal Seps | 2021 |
Transdermal Buprenorphine for Controlling Pain in Patients with Critical Lower-Limb Ischemia.
Topics: Administration, Cutaneous; Analgesics, Opioid; Buprenorphine; Humans; Ischemia; Pain; Pain Managemen | 2020 |
The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Cohort Studies; Female; Humans; Ischemia; Kidney Fa | 2017 |
Novel nitric oxide producing probiotic wound healing patch: preparation and in vivo analysis in a New Zealand white rabbit model of ischaemic and infected wounds.
Topics: Administration, Cutaneous; Animals; Equipment Design; Free Radical Scavengers; Ischemia; Male; Nitri | 2012 |